Tranexamic Acid EP Impurity D/USP RC D is a known related compound associated with the synthesis, degradation, or manufacturing process of Tranexamic. It is commonly used as a reference standard for impurity profiling and analytical studies.

Tranexamic Acid EP Impurity D/USP RC D helps pharmaceutical companies identify, quantify, and monitor impurities, ensuring product quality and regulatory compliance.

Tranexamic Acid EP Impurity D/USP RC D can be analyzed using HPLC, UPLC, LC-MS, GC-MS (where applicable), and other advanced chromatographic and spectroscopic techniques.

Yes, Tranexamic Acid EP Impurity D/USP RC D is widely used as a reference standard for qualitative and quantitative analysis of impurities in pharmaceutical products.

It assists in establishing specificity, accuracy, precision, linearity, detection limits, and quantification limits during analytical method validation studies.

Tranexamic Acid EP Impurity D/USP RC D can be sourced from Chemicea, a trusted supplier of pharmaceutical impurities, reference standards, metabolites, and analytical research materials for the pharmaceutical industry.

Tranexamic Acid EP Impurity D/USP RC D may form during the synthesis, purification, storage, or degradation of the parent drug substance under specific process or environmental conditions.

Chemicea provides COA, H-NMR, MASS, HPLC, and TGA reports as standard with Tranexamic Acid EP Impurity D/USP RC D. Additional reports such as CNMR, IR, UV, DEPT, Water Content, and CHNS can be provided upon request, subject to availability.

The CAS number for Tranexamic Acid EP Impurity D/USP RC D is 56-91-7.